washingtonlos angeles reuters u president donald trump meeting tuesday pharmaceutical executive call manufacture drug united state cut price vow speed approval new medicine ease regulation
trump tell government pay “ astronomical ” price medicine health program older disabled poor people say would soon appoint new u food drug administration leader
“ ’ go streamline fda ” trump say statement refer regulatory agency responsible vet new drug safe effective
meeting trump pharmaceutical executive signal defusing tension keep drug stock price check since presidential election
share group rally tuesday follow meeting even broader stock market slide
“ trump populist else drug price skyrocket ’ comment administration go happen ” say market strategist quincy crosby prudential financial newark new jersey
say trump play balance act control price loosen regulation
“ ’ think majority american want regulation lift drug maker ” attend meeting top executive merck co inc johnson celgene corp eli lilly co amgen inc switzerland ’ novartis ag nov n well head pharmaceutical research manufacturer america phrma lobbying group
accord transcript televised portion meeting amgen chief executive officer robert brad way promise add 1600 u job californiabased biotechnology company year
amgen clarify email currently employ around 20000 people worldwide include 12000 united state say 1600 include new staff well hire address attrition
celgene lilly merck amgen say email meeting encourage trump ’ focus innovation tax reform need valuedriven health care system
lilly say discussion topic also include stronger trade agreement remove “ outdated regulation drive cost slow innovation ” phrma echo point postmeeting statement add policy enact would result 350000 new job next 10 year
“ tax deregulation thing could really help u expand operation ” lilly ceo dave rick say
official novartis jj immediately respond request additional comment
share six company mostly higher overall gain average 07 percent compare 04 percent drop broad sp 500
nasdaq biotech index 12 percent reverse earlier loss sp 500 health care index gain 06 percent
“ get price lot reason
choice medicare medicaid ” trump say cite nation ’ government insurance program elderly poor disabled
trump also say currency devaluation country increase drugmakers ’ outsource production call company make product united state
foreign country must pay fair share drug development cost add
“ ’ go end global freeloading ” united state typically pay drug developed nation
western european country well japan governmentrun health care coverage drug price negotiate
high drug price become national issue past two year healthcare cost rise trump spook pharmaceutical biotech investor say jan 11 inauguration drug company “ get away murder ” charge government medicine would something
company executive meanwhile try tread careful line defend industry express optimism united state would continue reward scientific advance
“ regulation great streamline fda perhaps ” jack ablin chief investment officer bmo private bank chicago say
“ trump go address constituency drug price come
think maybe pyrrhic victory ”